These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26159837)

  • 1. Development of a high-throughput in vitro intestinal lipolysis model for rapid screening of lipid-based drug delivery systems.
    Mosgaard MD; Sassene P; Mu H; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2015 Aug; 94():493-500. PubMed ID: 26159837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Throughput Lipolysis in 96-Well Plates for Rapid Screening of Lipid-Based Drug Delivery Systems.
    Mosgaard MD; Sassene PJ; Mu H; Rades T; Müllertz A
    J Pharm Sci; 2017 Apr; 106(4):1183-1186. PubMed ID: 28057543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vivo Precipitation of Poorly Soluble Drugs from Lipid-Based Drug Delivery Systems.
    Sassene PJ; Michaelsen MH; Mosgaard MD; Jensen MK; Van Den Broek E; Wasan KM; Mu H; Rades T; Müllertz A
    Mol Pharm; 2016 Oct; 13(10):3417-3426. PubMed ID: 27533712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fed and fasted state gastro-intestinal in vitro lipolysis: In vitro in vivo relations of a conventional tablet, a SNEDDS and a solidified SNEDDS.
    Christophersen PC; Christiansen ML; Holm R; Kristensen J; Jacobsen J; Abrahamsson B; Müllertz A
    Eur J Pharm Sci; 2014 Jun; 57():232-9. PubMed ID: 24056027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simulating the digestion of lipid-based drug delivery systems (LBDDS): overview of in vitro lipolysis models.
    Bolko K; Zvonar A; Gašperlin M
    Acta Chim Slov; 2014; 61(1):1-10. PubMed ID: 24664320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A lipid-based liquid crystalline matrix that provides sustained release and enhanced oral bioavailability for a model poorly water soluble drug in rats.
    Boyd BJ; Khoo SM; Whittaker DV; Davey G; Porter CJ
    Int J Pharm; 2007 Aug; 340(1-2):52-60. PubMed ID: 17467935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous lipolysis/permeation in vitro model, for the estimation of bioavailability of lipid based drug delivery systems.
    Bibi HA; Holm R; Bauer-Brandl A
    Eur J Pharm Biopharm; 2017 Aug; 117():300-307. PubMed ID: 28478159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simplified method to screen for in-vivo performance of oral lipid formulations.
    Kilic M; Dressman J
    J Pharm Pharmacol; 2014 May; 66(5):615-23. PubMed ID: 24313318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water-soluble drugs II. In-vivo evaluation.
    Nguyen TH; Hanley T; Porter CJ; Larson I; Boyd BJ
    J Pharm Pharmacol; 2010 Jul; 62(7):856-65. PubMed ID: 20636873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An in vitro digestion test that reflects rat intestinal conditions to probe the importance of formulation digestion vs first pass metabolism in Danazol bioavailability from lipid based formulations.
    Anby MU; Nguyen TH; Yeap YY; Feeney OM; Williams HD; Benameur H; Pouton CW; Porter CJ
    Mol Pharm; 2014 Nov; 11(11):4069-83. PubMed ID: 25265395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterising lipid lipolysis and its implication in lipid-based formulation development.
    Thomas N; Holm R; Rades T; Müllertz A
    AAPS J; 2012 Dec; 14(4):860-71. PubMed ID: 22956477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating the correlation between in vivo absorption and in vitro release of fenofibrate from lipid matrix particles in biorelevant medium.
    Borkar N; Xia D; Holm R; Gan Y; Müllertz A; Yang M; Mu H
    Eur J Pharm Sci; 2014 Jan; 51():204-10. PubMed ID: 24134899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the fate of liposomes in the intestine by dynamic in vitro lipolysis.
    Parmentier J; Thomas N; Müllertz A; Fricker G; Rades T
    Int J Pharm; 2012 Nov; 437(1-2):253-63. PubMed ID: 22939968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro lipolysis and intestinal transport of β-arteether-loaded lipid-based drug delivery systems.
    Memvanga PB; Eloy P; Gaigneaux EM; Préat V
    Pharm Res; 2013 Oct; 30(10):2694-705. PubMed ID: 23739990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the commonly used pH-stat method with back titration really quantify the enzymatic digestibility of lipid drug delivery systems? A case study on solid lipid nanoparticles (SLN).
    Heider M; Hause G; Mäder K
    Eur J Pharm Biopharm; 2016 Dec; 109():194-205. PubMed ID: 27789354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precipitation of a poorly soluble model drug during in vitro lipolysis: characterization and dissolution of the precipitate.
    Sassene PJ; Knopp MM; Hesselkilde JZ; Koradia V; Larsen A; Rades T; Müllertz A
    J Pharm Sci; 2010 Dec; 99(12):4982-91. PubMed ID: 20574997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro Lipolysis as a Tool for the Establishment of IVIVC for Lipid-Based Drug Delivery Systems.
    Verma R; Kaushik D
    Curr Drug Deliv; 2019; 16(8):688-697. PubMed ID: 31250755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward the establishment of standardized in vitro tests for lipid-based formulations, part 6: effects of varying pancreatin and calcium levels.
    Sassene P; Kleberg K; Williams HD; Bakala-N'Goma JC; Carrière F; Calderone M; Jannin V; Igonin A; Partheil A; Marchaud D; Jule E; Vertommen J; Maio M; Blundell R; Benameur H; Porter CJ; Pouton CW; Müllertz A
    AAPS J; 2014 Nov; 16(6):1344-57. PubMed ID: 25274609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A; Hoffman A
    J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid-Based Formulations Can Enable the Model Poorly Water-Soluble Weakly Basic Drug Cinnarizine To Precipitate in an Amorphous-Salt Form During In Vitro Digestion.
    Khan J; Rades T; Boyd BJ
    Mol Pharm; 2016 Nov; 13(11):3783-3793. PubMed ID: 27631273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.